Thalidomide to Chemotherapy Related Nausea and Vomiting in Pancreatic Cancer

Clinical trial NCT06017284 · RECRUITING

Trial details

NCT number: NCT06017284
Sponsor: Fudan University
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Pancreatic Cancer Stage IV Chemotherapy-induced Nausea and Vomiting

Start date: 2023-11-01
Primary completion: 2025-11-30
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.